N Verses Capital, LLC Tenaya Therapeutics, Inc. Transaction History
N Verses Capital, LLC
- $167 Billion
- Q2 2024
A detailed history of N Verses Capital, LLC transactions in Tenaya Therapeutics, Inc. stock. As of the latest transaction made, N Verses Capital, LLC holds 3,300 shares of TNYA stock, worth $6,600. This represents 0.01% of its overall portfolio holdings.
Number of Shares
3,300Holding current value
$6,600% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding TNYA
# of Institutions
97Shares Held
55.6MCall Options Held
30.3KPut Options Held
600-
Column Group LLC San Francisco, CA9.4MShares$18.8 Million40.92% of portfolio
-
Ra Capital Management, L.P. Boston, MA7.62MShares$15.2 Million0.36% of portfolio
-
Casdin Capital, LLC New York, NY6.73MShares$13.5 Million1.81% of portfolio
-
Black Rock Inc. New York, NY4.07MShares$8.15 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.51MShares$7.03 Million0.0% of portfolio
About Tenaya Therapeutics, Inc.
- Ticker TNYA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,364,700
- Market Cap $82.7M
- Description
- Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develops its products through cellular regeneration, gene therapy, and precision medicine platforms. The company is developing TN-201, an adeno-associated virus (AAV)-based gene therapy to address genetic hyp...